B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Vandetanib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Vandetanib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

canertinib
80 shared targets
cediranib
70 shared targets
foretinib
94 shared targets
erlotinib
64 shared targets
bosutinib
86 shared targets
doramapimod
55 shared targets
saracatinib
43 shared targets
gefitinib
50 shared targets
tozasertib
82 shared targets
raf
46 shared targets
Loading evidence profile...

This evidence profile for Vandetanib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.